BAXTER INTERNATIONAL INC. Increase (Decrease) in Accounts Receivable
BAXTER INTERNATIONAL INC. (BAX) reported Increase (Decrease) in Accounts Receivable of $4.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-30
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $156.00M, a 136.36% increase year-over-year.
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$152.00M.
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $88.00M, a 388.89% increase year-over-year.
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $4.00M, a 80.95% decline year-over-year.
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts receivable for fiscal 2025 was $132.00M, a 277.14% increase from fiscal 2024.
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts receivable for fiscal 2024 was $35.00M, a 7.89% decline from fiscal 2023.
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts receivable for fiscal 2023 was $38.00M, a 20.83% decline from fiscal 2022.
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts receivable for fiscal 2022 was $48.00M, a 71.76% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $156.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $4.00M 10-Q · filed 2026-07-30 | $92.00M derived: sum of 3 quarters · filed 2026-07-30 | $96.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$152.00M 10-Q · filed 2026-04-30 | -$64.00M derived: sum of 2 quarters · filed 2026-04-30 | -$60.00M derived: sum of 3 quarters · filed 2026-04-30 | $6.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $88.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $92.00M derived: sum of 2 quarters · filed 2026-02-12 | $158.00M derived: sum of 3 quarters · filed 2026-07-30 | $132.00M 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $70.00M derived: sum of 2 quarters · filed 2026-07-30 | $44.00M 10-Q · filed 2025-11-04 | $62.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $66.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $40.00M 10-Q · filed 2026-07-30 | $58.00M derived: sum of 3 quarters · filed 2026-07-30 | $79.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$26.00M 10-Q · filed 2026-04-30 | -$8.00M derived: sum of 2 quarters · filed 2026-04-30 | $13.00M derived: sum of 3 quarters · filed 2026-04-30 | $134.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $39.00M derived: sum of 2 quarters · filed 2026-02-12 | $160.00M derived: sum of 3 quarters · filed 2026-02-12 | $35.00M 10-K · filed 2026-02-12 | ||||
| 2024-09-30 | $21.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $142.00M derived: sum of 2 quarters · filed 2025-11-04 | $17.00M 10-Q · filed 2025-11-04 | $107.00M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | $121.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$4.00M 10-Q · filed 2025-08-05 | $23.00M 10-Q · filed 2024-08-06 | $86.00M derived: sum of 3 quarters · filed 2026-02-12 | $136.00M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-03-31 | -$125.00M 10-Q · filed 2025-05-06 | -$137.00M 10-Q · filed 2024-05-02 | -$35.00M derived: sum of 2 quarters · filed 2026-02-12 | $15.00M derived: sum of 3 quarters · filed 2026-02-12 | $61.00M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2023-12-31 | $90.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $140.00M derived: sum of 2 quarters · filed 2026-02-12 | $186.00M derived: sum of 3 quarters · filed 2026-02-12 | $38.00M 10-K · filed 2026-02-12 | $66.00M 10-K · filed 2024-02-08 | |||
| 2023-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $96.00M derived: sum of 2 quarters · filed 2024-11-12 | -$52.00M 10-Q · filed 2024-11-12 | -$55.00M 10-Q · filed 2023-11-02 | -$78.00M derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2023-06-30 | $46.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$102.00M 10-Q · filed 2024-08-06 | -$128.00M derived: sum of 3 quarters · filed 2025-02-21 | $1.00M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | -$148.00M 10-Q · filed 2024-05-02 | -$136.00M 10-Q · filed 2023-04-27 | -$174.00M derived: sum of 2 quarters · filed 2025-02-21 | -$45.00M derived: sum of 3 quarters · filed 2025-02-21 | $53.00M derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2022-12-31 | -$26.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $103.00M derived: sum of 2 quarters · filed 2025-02-21 | $201.00M derived: sum of 3 quarters · filed 2025-02-21 | $48.00M 10-K · filed 2025-02-21 | $125.00M 10-K · filed 2024-02-08 | |||
| 2022-09-30 | $129.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $227.00M derived: sum of 2 quarters · filed 2023-11-02 | $74.00M 10-Q · filed 2023-11-02 | $116.00M 10-Q · filed 2022-10-27 | $116.00M derived: sum of 4 quarters · filed 2024-02-08 | |||
| 2022-06-30 | $98.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | -$55.00M 10-Q · filed 2023-07-27 | -$13.00M derived: sum of 3 quarters · filed 2024-02-08 | |||||
| 2022-03-31 | -$153.00M 10-Q · filed 2023-04-27 | -$111.00M derived: sum of 2 quarters · filed 2024-02-08 | ||||||
| 2021-12-31 | $42.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $170.00M 10-K · filed 2024-02-08 | ||||||
| 2021-09-30 | $128.00M 10-Q · filed 2022-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |